Sulaquin, Gina F.

HRN: 21-53-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2022
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
07/10/2022
07/14/2022
VIA OGT
0.5mg
OD
T/c Pertussis, Cannot Totally Rule Out Cardiac Pathology
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaURTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: